Navigation Links
Biostar Pharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results
Date:8/14/2009

atements, within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended, which involve a number of risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding the success of our investments, risks and uncertainties regarding fluctuations in earnings, our ability to sustain our previous levels of profitability including on account of our ability to manage growth, intense competition, wage increases in China, our ability to attract and retain highly skilled professionals, time and cost overruns on fixed-price, fixed-time frame contracts, client concentration, our ability to successfully complete and integrate potential acquisitions, withdrawal of governmental fiscal incentives, political instability and regional conflicts and legal restrictions on raising capital or acquiring companies outside China. Additional risks that could affect our future operating results are more fully described in our United States Securities and Exchange Commission filings including our S-1 dated June 27, 2008, our Quarterly Report on Form 10-Q for the quarter ended March 31, 2009, our 10-K for the year ended December 31, 2008, and other recent filings. These filings are available at http://www.sec.gov . We may, from time to time, make additional written and oral forward-looking statements, including statements contained in our filings with the Securities and Exchange Commission and our reports to shareholders. We do not undertake to update any forward-looking statements that may be made from time to time by or on our behalf.

    For further information, please contact:

     Ms. Elaine Zhao, CFO
 
'/>"/>
SOURCE Biostar Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Biostar Pharmaceuticals, Inc. to Host Fiscal Year 2009 Second Quarter Earnings Conference Call on Friday, August 14, 2009 at 10:30 a.m. EDT
2. Biostar Pharmaceuticals, Inc. Retains HC International, Inc. to Implement Investor Relations Program
3. Biostar Pharmaceuticals, Inc. Reports Continued Revenues and Earnings Growth in First Quarter of 2009
4. Biostar Pharmaceuticals, Inc. Reports Record Revenues and Earnings for 2008
5. Inverness Medical Innovations to Close Cholestech, HemoSense and BioStar Facilities
6. Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009
7. Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results
8. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2009 Financial Results on Thursday, August 6, 2009 at 8:30am EDT
9. Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo(R) in the United States
10. Lotus Pharmaceuticals, Inc. Announces Patent Pending Gliclazide-Controlled Release Tablets
11. Angiotech Pharmaceuticals, Inc. announces filing of shelf-registration statement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2014)... FAIRFIELD, Conn. (PRWEB) November 28, 2014 ... (AACN) has honored Fairfield University’s School of Nursing ... in Nursing Leadership (LEAD) program. The 2014 Innovations ... work of AACN member schools and supports them ... It was recently presented at AACN’s annual meeting ...
(Date:11/27/2014)... November 27, 2014 Spartan Bioscience today ... Food and Drug Safety (MFDS) regulatory approval for its ... genetic results in less than 60 minutes from a ... as an aid for doctors to determine therapeutic strategies ... These include some of the world’s most commonly prescribed ...
(Date:11/26/2014)... 2014 (PRWEB) November 26, 2014 Publicis ... network, today announced the organization has won a total ... Awards. Digitas Health LifeBrands was honored with a Silver ... PHCG agencies received eight Awards of Excellence. , ... of pharmaceutical advertising and promotion. The Awards provide a ...
(Date:11/26/2014)... In keeping with the holiday spirit, ... of last-minute Thanksgiving savings. The company is offering up ... product lines this holiday weekend as well as a ... and Cyber Monday are right around the corner, and ... loyal customers and those looking to explore their ancestry, ...
Breaking Biology Technology:American Association of Colleges of Nursing honors Fairfield University’s School of Nursing for Re-envisioning Nursing Education 2Spartan Bioscience Receives Korean Regulatory Approval for First Rapid DNA Test of Mutations Affecting Metabolism of Common Drugs 2Spartan Bioscience Receives Korean Regulatory Approval for First Rapid DNA Test of Mutations Affecting Metabolism of Common Drugs 3Publicis Healthcare Wins 20 Rx Club Awards 2Publicis Healthcare Wins 20 Rx Club Awards 3DNA Spectrum Offers Last Minute Thanksgiving Coupons 2DNA Spectrum Offers Last Minute Thanksgiving Coupons 3
... (Nasdaq: NLTX ), today announced that it ... peptide franchise, including CD-NP which is in Phase II ... a pre-clinical compound. Nile will suspend the further development ... to Dr. Cesare Casagrande. "We are disappointed that we ...
... China, Jan. 20 /PRNewswire-Asia-FirstCall/ -- China-Biotics, ... "the Company"), a leading Chinese firm,specializing ... and,distribution of probiotics products, today announced ... approved manufacturing certificates for the production ...
... MARINO, Calif., Jan. 20 Epeius Biotechnologies ... Phase I/II study evaluating the safety and efficacy of ... #249; Sant P Chawla, P.I., Santa Monica CA, January ... no dose-limiting toxicity. At Dose Level I, three patients ...
Cached Biology Technology:Nile Therapeutics Announces Focus on CD-NP for Acute Heart Failure and Termination of 2NTX-99 Program 2Nile Therapeutics Announces Focus on CD-NP for Acute Heart Failure and Termination of 2NTX-99 Program 3Nile Therapeutics Announces Focus on CD-NP for Acute Heart Failure and Termination of 2NTX-99 Program 4China-Biotics, Inc. Receives Manufacturing Certificate for New Products 2China-Biotics, Inc. Receives Manufacturing Certificate for New Products 3REXIN-G Shrinks Metastatic Tumors and Triples Survival Time in Chemotherapy-Resistant Pancreatic Cancer: Analysis of a U.S. Phase I/II Clinical Trial (Proceedings of ASCO GI Symposium 2009) 2
(Date:11/6/2014)... for a predator. Except when that predator runs so fast ... to its size, is the fastest creature on Earth. Some ... second (at about five miles per hour). The fastest human ... gold from the tiger beetle, a person would have to ... has a problem. At peak speeds, everything becomes a blur. ...
(Date:11/5/2014)... biology in the UTSA College of Sciences, is ... to receive a two-year $300,00 National Science Foundation ... The funding supports President Obama,s BRAIN Initiative, a ... technology that will demystify complex brain processes. ... are broken into the interactions of multiple components, ...
(Date:11/5/2014)... de Janeiro, Brazil -Individuals show great diversity in their ... males and females greatly differ in their perceptual evaluation ... of smell tests. , Sex differences in ... behaviors and may be connected to one,s perception of ... emotions. Thus, women,s olfactory superiority has been suggested to ...
Breaking Biology News(10 mins):The tiger beetle: Too fast to see 2UTSA biology professor awarded $300,000 NSF grant for brain research 2UTSA biology professor awarded $300,000 NSF grant for brain research 3The female nose always knows: Do women have more olfactory neurons? 2
... The American Institute of Biological Sciences (AIBS) has ... of California, Davis, Ryan Richards, a graduate student at ... a graduate student at the University of Rhode Island, ... Award (EPPLA). "AIBS is committed to fostering ...
... For centuries, seafarers were plagued by wood-eating gribble ... wreak damage on wooden piers and docks in coastal ... the BBSRC Sustainable Bioenergy Centre at the Universities of ... isopod digests the apparently indigestible. , By examining ...
... N.Y. - Another weapon in the arsenal against cancer: ... while leaving healthy cells alone. Led by Carl ... the researchers synthesized nanoparticles shaped something like a ... of iron oxide. They then attached antibodies, which target ...
Cached Biology News:AIBS names emerging public policy leaders 2AIBS names emerging public policy leaders 3Seafarers' scourge provides hope for biofuel future 2Like little golden assassins, 'smart' nanoparticles identify, target and kill cancer cells 2
... antigen and antibody-based immunoaffinity matrices, such ... many times without compromising antigen-antibody reactivity, ... chaotropic agents has precluded the application ... The CHEMICON Re-Blot Plus Western ...
... MX80 Series of positioning slides offers ... ballscrew, leadscrew, micrometer, and manual. With ... performance, cost-effective multi-axis systems. These slides ... encoder resolutions down to 10 nanometers, ...
Ethylene glycol-bis(2-aminoethyl ether)-N,N,N',N'-tetraacetic acid...
... The Deletion Kit for Kilo-Sequencing is designed ... fragments cloned into the multiple cloning sites ... pUC-related plasmid or phagemid vectors (pUC18/19). The ... deletions in the target DNA, thereby progressively ...
Biology Products: